Pancreas Market Analysis and Reports | USA Conference Series

Market Analysis - Pancreas 2017

Pancreas 2017 Scientific Committee is honored to invite you to the 2nd International Conference on Pancreatic Disorders and Treatment (Pancreas 2017) to be held in the beautiful city Dallas, Texas, USA during September 13-14, 2017. The conference proceedings will include seminars, symposiums and workshops on the latest treatment innovations of various pancreatic diseases, speeches delivered by eminent surgeons, gastroenterologists, endocrinologists and many enthusiastic young researchers.

Distributer's "Pancreatic Cancer - Market Insights, Epidemiology and Market Size Forecast-2020" Reports gives a diagram of the malady and worldwide market size of the Pancreatic Cancer for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It likewise incorporates worldwide chronicled and determined epidemiological information for the analyzed occurrence instances of Pancreatic Cancer from 2010-2020.Pancreatic disease emerges when cells in the pancreas, a glandular organ behind the stomach, start to increase wild and shape a mass. The most widely recognized, pancreatic adenocarcinoma, represents around 85% of cases. Those cases not treatable with surgery have a normal five-year survival rate of 16%.Globally pancreatic tumor is the eleventh most regular growth in ladies and the twelfth most basic in men. Endeavors are in progress to grow new medications. Some of these include focused on treatments against the growth cells' atomic components. Others plan to focus on the very safe malignancy undifferentiated organisms. A further approach includes the utilization of immunotherapy, for example, oncolytic infections.

The Pancreatic and Interventional Endoscopy Services at Cedars-Sinai spends significant time in diagnosing and treating the full range of infections of the pancreas and bile conduits. In the most recent couple of years, incredible steps have been made in indicative and remedial devices. Today, they are more precise and less intrusive than customary systems. The following is a brief depiction of some of these therapeutic achievements.

Scope

It is estimated that by 2020, in USA and 2030 in Europe, pancreatic cancer and related diseases are going to become the second most leading cause of cancer death. This rate is calculated as a total of 10% of the cancer death rates. There are number of pharmaceutical companies trying to make drugs for the treatment of pancreatic diseases. The estimated growth of pancreatic market by the end of this decade is

The global market value of this organ’s syndromes have increased from 850 Million back in the beginning of this decade to current market value is around 1.2 Billion USD.

The worldwide constant pancreatitis torment market can be fragmented in view of treatment sort, and topography. Treatments used to treat ceaseless pancreatitis torment incorporate medicinal treatment, endoscopic treatment and surgery. Therapeutic treatment is the main line of treatment in constant agony administration and might be further delegated nonspecific strong treatment, pancreatic proteins, octreotide, and cell reinforcement treatment. Pain relieving medications are the most ordinarily utilized technique to regard the simultaneous manifestations as a strong treatment. Now and again, antidepressants and calming medications are likewise utilized as an attending treatment. The utilization of oral pancreatic chemicals has been variable. These catalysts supplant the ordinarily delivered pancreatic proteins; in any case, these chemicals are not known to be successful in all individuals. Octreotide are cholecystokinin-receptor foes that restrain pancreatic discharge and in this manner is known to be powerful in diminishing the endless agony.  

 

The other Major Companies working on the developing Artificial Vital Organs are

Abbott Diabetes Care
AbioMed
Baxter International
Fresenius Medical Care
Thoratec Corporation
Otto Bock Healthcare
SynCardia Systems, Inc.
WorldHeart Corporation

The other competitive pancreas product developers are

AB Science
AbGenomics International
Aduro Biotech
Aphios
Celsion
Gilead Sciences
Halozyme Therapeutics
Merrimack Pharmaceuticals
Momenta Pharmaceuticals
Novartis
OncoMed Pharmaceuticals
OncozymePharma
Ostuka Holdings
Rexahn Pharmaceuticas
Zeria Pharmaceutica

The top pharmaceutical companies in the pancreas market are

Eli Lilly
Genentech
OSI Pharmaceuticals
Roche
Celgene
Pfizer
Merck's
Sanofi
Lantus

National Funding Organizations (USA)

National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
NIH Loan Repayment Programs
NIH Director’s Pioneer Award
NIH Director’s Early Independence Award (EIA)
Congressionally Directed Medical Research Programs (CDRMP), Department of Defense (DOD)
National Institute of Nursing Research
U.S. Food and Drug Administration Orphan Products Grant Program

Private Foundations Funding Cancer Research (USA)

Pancreatic Cancer Action Network
American Cancer Society
American Association for Cancer Research
American Gastroenterological Association
Burroughs Wellcome Fund
Caring for Carcinoid Foundation
The Damon Runyon Cancer Research Foundation
Doris Duke Charitable Foundation
Hirshberg Foundation for Pancreatic Cancer Research
The Lustgarten Foundation
Michael Rolfe Pancreatic Cancer Foundation
The National Pancreas Foundation
National Foundation for Cancer Research
The Robert Wood Johnson Foundation
Sidney Kimmel Foundation for Cancer Research
Stand Up To Cancer

Currently, there have been up to 40 million USD have been released by two of these private organizations to researchers and physicians who are working on pancreatic research and more are going to be released very soon. The National grants available for the research are estimated at about 100 Million USD. The number of physicians working on pancreas and its related ailments in the United States are

Institutes associated with pancreatic research (Illinois, Chicago)

Pritzker School of Medicine
Feinberg School of Medicine
University of Illinois College of Medicine
Rush Medical College
Loyola-Stritch School of Medicine

The top universities conducting pancreatic research (USA)

John Hopkins
Universitiy of Michigan
University of Pittsburgh
University of Massachussettes
University of Columbia
University of Pennsylvania
University of Chicago
M D Anderson
University of Southern California
University of California Los Angeles

The top 10 Universities (World)

Massachusetts Institute of Technology (MIT)
University of Cambridge
Imperial College London
Harvard University
University of Oxford
Stanford University
California Institute of Technology
Princeton University
Yale University
University of Chicago

Top Societies and Associations (Illinois, Chicago)

Cancer Wellness Center
Wellness House
Jennifer S. Fallick Cancer Support Center
The Rolfe Pancreatic Cancer Foundation
Cystic Fibrosis Foundation, Greater Illinois Chapter

Top Societies (USA)

American Pancreatic Association
American Cancer Society
PanCan
National Pancreatic Cancer Foundation
Americas Hepato-Pancreato-Biliary Association
Pancreatic Cancer Action‎
The Hirshberg Foundation For Pancreatic Cancer Research
Kenner Family Research Fund
Lustgarten Foundation
National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)
Pancreas Club

Societies of Pancreatic Diseases (European region)

The European Pancreatic Club
International Association of Pancreatology
European Society of Pediatric Gastroenterology
European Society for Medical Oncology
International Hepato-Pancreato-Biliary Association
European Society of Gastrointestinal and Abdominal Radiology
European Study Group of Pancreatic Cancer (ESPAC)
Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer (MolDiag-PaCa)
European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC)
The Pancreatic Society of Great Britain and Ireland

The top societies for pancreas research (Asia Pacific region)

Japanese Pancreas Society
Korean Pancreatobiliary Association
Asian-Pacific Hepatic-Pancreato-Biliary Association
Singapore Society of Oncology
Pancreas Study Group, Chinese Society of Gastroenterology
Asian Society Of Hepatobiliary Pancreatic Surgery
Asian-Oceanic Pancreatic Association

Funding in Millions

Funding in USA for pancreatic research and pancreatic cancer research only for the year 2015 is estimated at 40 Million USD.

As mentioned earlier, the major funding institutes still are the government aided funding institutions like NIH, NIDDK, FDA etc. are contributing nearly 228 Million while the other public and private funding agencies are able to collect a meagre 80-100 Million. The amount of fund available in the UK market are averaging at 128 Million GBP.